Cryoport Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Cryoport Inc 's ROA in the second quarter of 2026?
Cryoport Inc recorded a cumulative net loss of $-43 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -5.03%.

However, within the Healthcare sector 261 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 604, from total ROA ranking in the first quarter of 2026 at 695.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	47.99 %	26.63 %	15.62 %	12.47 %	-7.87 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-43	74	72	65	73
Return On Assets (TTM)	-5.03 %	9.59 %	9.92 %	9.28 %	10.71 %
CYRX's Total Ranking	# 604	# 695	# 694	# 607	# 3513
Total Assets (TTM) in million	1,145	764	765	774	774
Seq. Total Assets Change	49.99 %	-0.18 %	-1.21 %	0.05 %	28.34 %
Seq. Net Income Change	-	-	-	-	-

CYRX's 5 Years Annual ROA >> Back to CYRX Management Effectiveness >> Compare CYRX ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 89
Sector	# 262
Overall	# 2968

Return On Assets Statistics
High	Average	Low
10.14 %	-153.83 %	-1254.69 %
(Jun 30 2025)		(Jun 30 2014)

Financial Statements
Cryoport Inc 's Assets	$ 1,145 million	CYRX's Balance sheet
Cryoport Inc 's Income	$ -8 million	Quarterly CYRX's Income Statement
CYRX's Income by Division		See CYRX's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2020
Y / Y Total Assets Change	8.74 %	-26.55 %	-7.8 %	-6.67 %	781.67 %
Total Assets in million	765	703	958	1,039	1,113
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	70	-123	-108	-45	-284
Annual Return On Assets	9.19 %	-17.45 %	-11.23 %	-4.36 %	-25.49 %

CYRX's 5 Years Annual ROA >> Back to CYRX Management Effectiveness >> Compare CYRX ROA to its Competitors

Comment on CYRX's ROA in the fiscal year ending 2025

In the fiscal year 2025 ROA improved to 9.19 % compared to prior year, due to annual net income growth of % to $70.30 million, while value of Cryoport Inc 's overall assets grew just by 8.74 % to $764.99 million, compared to $764.99 a year before.

More Return On Assets Ratios
CYRX's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
CYRX's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for CYRX's Competitors
Subscribers only: Roa for Cryoport Inc 's Suppliers
Subscribers only: Return On Assets for CYRX's Customers

You may also want to know
CYRX's Roi	CYRX's Inventory Turnover Ratio	CYRX's Growth Rates	CYRX's Dividend Comparisons
	CYRX's Profitability Ratios	CYRX's Asset Turnover Ratio	CYRX's Dividend Growth
CYRX's Roe	CYRX's Valuation Ratios	CYRX's Financial Strength Ratios	CYRX's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector

ROA

Date modified: 2026-09-12T06:10:03+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.